Pilėnų vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 605,181 | 636,959 | 722,336 | 743,209 | 863,243 | 958,374 | 980,572 | 1,097,332 |
| Profit before tax | 47,563 | 40,355 | 44,342 | -225 | 13,247 | 13,320 | -33,957 | -24,783 |
| Net profit | 40,428 | 34,302 | 37,735 | -225 | 11,260 | 11,205 | -33,957 | -24,783 |
| Equity | 81,469 | 101,771 | 124,506 | 99,481 | 92,741 | 88,646 | 38,689 | 6,846 |
| Liabilities | 76,812 | 77,241 | 86,787 | 142,898 | 158,956 | 117,248 | 180,976 | 199,356 |
| Non-current assets | 5,231 | 4,493 | 4,512 | 38,091 | 71,663 | 56,999 | 65,300 | 52,948 |
| Current assets | 153,050 | 174,519 | 206,781 | 204,288 | 180,034 | 148,895 | 154,365 | 153,254 |
| Total assets | 158,281 | 179,012 | 211,293 | 242,379 | 251,697 | 205,894 | 219,665 | 206,202 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 51,461 | 53,323 | 61,207 |
| Social insurance contributions | - | - | - | - | - | 36,825 | 41,795 | 50,128 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +6.2% | +5.3% | +13.4% | +2.9% | +16.2% | +11.0% | +2.3% | +11.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 25.5% | 19.2% | 17.9% | -0.1% | 4.5% | 5.4% | -15.5% | -12.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 49.6% | 33.7% | 30.3% | -0.2% | 12.1% | 12.6% | -87.8% | -362.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 6.7% | 5.4% | 5.2% | 0.0% | 1.3% | 1.2% | -3.5% | -2.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.9% | 6.3% | 6.1% | 0.0% | 1.5% | 1.4% | -3.5% | -2.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.9 | 0.8 | 0.7 | 1.4 | 1.7 | 1.3 | 4.7 | 29.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 67,242 | 65,892 | 70,472 | 68,604 | 78,477 | 81,564 | 85,889 | 97,541 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Pilėnų vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-06-16 | 2023-06-21 | 0.24 |
Pilėnų vaistinė - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Pilenu vaistine, UAB (code 159836331) is a Private Limited Liability Company engaged in retail sale of pharmaceutical products. In 2025, revenue increased to €1.10M, up 11.9% year on year and 14.5% over two years, showing steady top-line expansion. However, profitability remained negative: the company reported a net loss of €24.8K and a profit margin of -2.3%. This was an improvement from the €34.0K loss recorded in 2024, but it still followed a profitable 2023, when net profit was €11.2K on revenue of €958.4K. The three-year trend therefore shows revenue growth accompanied by a deterioration in earnings after 2023, with only partial recovery in 2025. In the 2025 balance sheet, total assets were €206.2K, equity €6.8K and liabilities €199.4K, which points to a very low equity base and heavy reliance on liabilities. Long-term assets were €52.9K and short-term assets €153.3K. Asset turnover was 5.32x, revenue per employee was €99.8K, and profit per employee was -€2.3K. Returns on assets were negative in 2025.